Sign in

CIK 0000818033

  • Accelerated filer

HERON THERAPEUTICS, INC. /DE/

Sign in to watch
Ticker
HRTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
942875566
Phone
+1 858-251-4400
Business address
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
Former names
AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
  1. 4 Shares withheld for taxes EVP, Chief Financial Officer gave up 1,122 shares (to pay taxes)
  2. 4 Exercise or conversion EVP, Chief Development Officer acquired 3,874 shares (option exercise)
  3. 4 Exercise or conversion Chief Executive Officer acquired 13,797 shares (option exercise)
  4. 4 Exercise or conversion Chief Executive Officer acquired 62,500 shares (option exercise)
  5. 4 Grant or award Director acquired 13,948 shares (grant or award)
  6. 4 Grant or award Director acquired 13,948 shares (grant or award)
  7. 4 Grant or award Director acquired 13,948 shares (grant or award)
  8. 4 Grant or award Director acquired 13,948 shares (grant or award)
  9. 4 Grant or award Director acquired 13,948 shares (grant or award)
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Shares withheld for taxes VP, Chief Accounting Officer gave up 756 shares (to pay taxes)
  15. 4 Open-market buy EVP, Chief Development Officer bought 25,000 shares at $1.09 ($27,250)
  16. 4 Open-market buy EVP, Chief Development Officer bought 50,000 shares at $0.94 ($46,995)
  17. 4 Open-market buy Chief Executive Officer bought 150,000 shares at $0.92 ($137,970)
  18. 4 Open-market buy EVP, Chief Financial Officer bought 85,000 shares at $0.89 ($75,599)
  19. 4 Shares withheld for taxes VP, Chief Accounting Officer gave up 15,603 shares (to pay taxes)
  20. 4 Shares withheld for taxes Chief Executive Officer gave up 692 shares (to pay taxes)

Page 6 of 30 · 585 filings